Sanofi intends to become R&D machine; Senior Pfizer exec new CEO of WebMD;

 @FiercePharma: PhRMA emails show behind-the-scenes dickering on industry's healthcare reform deal--WSJ. More | Follow @FiercePharma

> Cavan M. Redmond, a senior executive at Pfizer ($PFE), has been named CEO of online health company WebMD. Story

> Elias Zerhouni, president of global R&D at Sanofi ($SNY), told reporters Thursday that the French drugmaker intends to be the R&D machine in the industry by 2015. Report

> Forest Laboratories ($FRX) on Friday said it will pay Austrian drugmaker Nabriva Therapeutics $25 million to partner up on an infection drug and has an option to buy the whole company. Article

> Cardinal Health ($CAH) will manufacture and distribute Eli Lilly's ($LLY) Amyvid, a new diagnostic imaging agent used for patients being evaluated for Alzheimer's disease. Item

> Corruption tied to sales of drugs, both approved and fake, are areas of concern as the chief of China's Communist Party urges the government to crack down on low-level corruption. News

Biotech News

 @FierceBiotech: Forest labs nabs rights to anti-MRSA antibiotic from Nabriva for $25M. Release | Follow @FierceBiotech

 @JohnCFierce: Now this you hardly ever see: BMS CEO throws down the gauntlet on Gilead, demands combo hep C study. Check it out. News | Follow @JohnCFierce

 @RyanMFierce: How many times did Marina change its name during lackluster run? I count at least two changes. | Follow @RyanMFierce

> Genzyme/Sanofi's oral MS drug Aubagio beats placebo in PhIII. More

> New chairman ramps up CEO search at struggling AZ. Article

> Marina Biotech hits a funding wall, shuts down RNAi ops. Story

> Bristol CEO says Gilead holding out on hep C tie-up. News

Medical Devices News

 @MarkHFierce: Folks, there's still time to submit your nominations for the FierceMedicalDevices Fierce 15 private device developers. Survey | Follow @MarkHFierce

 @FierceMedDev: The House Ways and Means Committee voted to repeal the 2.3% device tax. Next: full House vote. More

> China's device industry boasts 13,000 home-grown companies. Story

> GI Dynamics and Gore headed to court in patent dispute. More

> Smith & Nephew stops sale of optional hip replacement metal part. News

> Medtronic teams with diabetes foundation on glucose monitors. Article

And Finally... For scientists looking for a new opportunity, they might note that Abbott Laboratories ($ABT), which has been on the Scientist magazine list of "Best Places to Work in Industry" since the list began nearly a decade ago, comes in at No. 14 for 2012. Release

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.